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Nephrotic Syndrome: Is HIV Associated
Nephropathy on Your Differential?
Jad Al Danaf, MD, Jeffrey Marbach, MD, Sharon Li, MS4, Emily Stewart, MD

Case Description
A 30-year old African American female with no significant
past medical history initially presented to our emergency
department with three days of sore throat, dysphagia,
fever, fatigue, nausea and vomiting. She denied ear pain,
rhinorrhea, shortness of breath or any sick contacts. Her
social history was negative for tobacco, alcohol and illicit
drug use. She works as a security officer, lives with her
family and is sexually active only with her husband. On
initial examination she was febrile to 101.9° F, with a heart
rate of 100 beats per minute, blood pressure of 143/99
mmHg, respiratory rate of 18 breaths per minute and an
oxygen saturation of 99% on room air. Her only pertinent
physical examination findings were a mildly erythematous
oropharynx without exudates, mildly swollen uvula and
right tonsil, bilateral tender swollen sub-mandibular
lymph nodes and reduced breath sounds on auscultation
of the right lower lung base.She was routinely tested for
HIV, ruled out for group A strep, and discharged home
with the diagnosis of viral pharyngitis on supportive care.
Following the identification of a presumptive positive
rapid HIV screening test with evidence of HIV-1 p24
antigen and a reactive HIV-1 antibody on the multispot
HIV 1 / 2 antibody test she was called to return to the ED
for counseling regarding a positive HIV test. She reported
continuation of her prior symptoms with worsening
dysphagia, as well as new complaints of bilateral lower
extremity edema to the knees. Initial laboratory testing
revealed an elevated serum creatinine (Cr) of 2.2mg/dL
(0.7-1.3 mg/dL) up from <1.0mg/dL one-year prior, with
an estimated Creatinine clearance (CrCl) of 43.4 ml/min
using the modified Cockcroft-Gault equation. She was
admitted for further workup. A trial of IV fluid hydration
overnight worsened her symptoms and additional labs
demonstrated hypoalbuminemia, 4+ proteinuria with
1+ blood, and a urine protein/creatinine ratio of 17mg/
mg (<0.2 mg/mg), consistent with nephrotic syndrome.
Her CD4 count was 115 cells/mm3 (500-1500 cells/
mm3) with an HIV viral load of 117,148 copies/ml.
Based off negative labs for syphilis, hepatitis panel, ANA,
complement C3/C4, and diabetes, findings were felt to
be consistent with HIV Associated Nephropathy (HIVAN).
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The patient underwent renal biopsy to confirm the diagnosis
and was started on abacavir, darunavir, dolutegravir,
lamivudine and ritonavir. Pathology results were consistent
with HIVAN with tubulointerstitial nephritis and collapsing
glomerulonephropathy and electron microscopy
showed diffuse epithelial cell injury with effacement of
foot processes and segmental collapse of glomerular
capillary loops. Her serum Cr peaked at 2.78 on day 7 of
her admission. Her serum Cr and urea-nitrogen steadily
improved after just one week of HAART therapy leading
to a 42% reduction in serum Cr (Figure 1). Additionally,
due to her un-resolving dysphagia the patient underwent
esophagogastroduodenoscopy, which was unremarkable.
However, she subsequently had esophageal manometry,
which was consistent with diffuse esophageal spasm for
which she was started on diltiazem.

Discussion
HIV-associated nephropathy (HIVAN) is an aggressive form
of collapsing focal segmental glomerulosclerosis and
tubulointerstitial lesions that is observed predominantly
in African Americans. The first descriptions of this
disease manifestation were among African-American
and Haitian immigrants with advanced HIV illness, which
serve to highlight the racial disparity and genetic susceptibility to HIVAN.1 The era of highly active antiretroviral
therapy (HAART) has reduced the incidence of HIVAN;
however, HIVAN remains the 3rd leading cause of end
stage renal disease (ESRD) among blacks between the
ages of 20-64 years old, with an estimated 90% of
patients with ESRD attributed to HIVAN being of AfricanAmerican descent.2 Although incompletely understood
it has been postulated that the pathogenesis of HIVAN
involves several factors, including direct HIV infection of
glomerular and tubular epithelial cells and upregulation
of host cellular pathways involved in apoptosis and
cell cycle arrest. 3-5 As previously mentioned, current
therapy involves initiation of HAART, along with renal
replacement therapy and renin-angiotensin system
inhibitors as warranted.
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Figure 1. Trend of serum
creatinine (Cr) (normal
range: 0.7-1.3 mg/dL)
and serum urea-nitrogen
(mg/dL) (normal range:
8-20 mg/dL) since
presentation to the ED
(day 0) across time (days).

Ultimately, HIV prevention remains the best approach to
impact the epidemiology of HIVAN. In this case report, it
was not clear for exactly how long the patient had HIV,
however if it was a recent transmission it would have
been a rare case of HIVAN in the setting of sub-acute HIV
infection. Additional high quality studies and randomized
clinical trials are needed to establish treatment beyond
HAART for HIVAN, taking into account the recent
progress in the understanding of the pathogenesis of
HIVAN in the existing body of literature. Furthermore, it
is still not clear which of the combination antiretroviral
therapies (cART) available are effective in treating HIVAN
and to what extent they are achieving survival and
morbidity reductions.
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Summary
This case serves as an example of an uncommon
yet dangerous complication of HIV. In the setting of
nephrotic syndrome, screening for HIV infection and
ruling out HIVAN in HIV-infected individuals is essential.
HIVAN may be the first manifestation of HIV-1 infection
in an otherwise asymptomatic patient and preservation
of renal function in African Americans with chronic
kidney disease and HIV is dependent upon its prompt
recognition and early treatment. Early recognition
and treatment of HIVAN has the potential to delay the
onset of ESRD and improve mortality associated with
complications of HIV.
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